|
Market Closed -
Nasdaq
23:00:00 26/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 2.040 USD | -5.99% |
|
-8.52% | +48.91% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-13 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
Chart: Technical Analysis
Stock exchange
Nasdaq
ALLO 2.040 $
-5.99%
10.19M
$
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
Nasdaq
| ALLO | 2.040USD | -5.99% | 10.19M $ | |
CBOE
| ALLO | 2.035USD | -6.00% | 215K $ |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Neutral | Neutral |
| Resistance | 2.23 | 3.06 | 2.78 |
| Spread/Res. | -8.52% | -33.33% | -26.62% |
| Spread/Supp. | +3.03% | +22.89% | +72.88% |
| Support | 1.98 | 1.66 | 1.18 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- ALLO Stock
- Charts Allogene Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
